CADLCandel Therapeutics, Inc.
$9.66+72% 1Y
$9.66
$4.4252 weeks$13.76
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +20% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How CADL is trading
Candel Therapeutics, Inc. is +72% over the past year while the S&P 500 is +18%: 53 points ahead of the market.
+72%
1-year return · S&P 500 +18%
- vs 200-day average
- +20%
vs 200-day average · a clear uptrend
- RSI (14)
- 37
RSI (14) · neutral
- Below its 52-week high
- 30%
Below its 52-week high
Details›
- Last close2026-10-08
- $9.66
- 1 monthS&P 500 +1.6%
- −21%
- 1 yearS&P 500 +18%
- +72%
- 5 yearsS&P 500 +86%
- −11%
- vs 50-day average$11.46
- −16%
- 52-week high
- $13.76
- 52-week low
- $4.42
- Annualised volatility
- 103%
| Year | Return |
|---|---|
| 2026 (year to date) | +71% |
| 2025 | −35% |
| 2024 | +490% |
| 2023 | −18% |
| 2022 | −77% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 2 of 5 | −5.7% |
| Feb | 5 | 2 of 5 | +5.2% |
| Mar | 5 | 1 of 5 | −12% |
| Apr | 5 | 2 of 5 | +65% |
| May | 5 | 5 of 5 | +19% |
| Jun | 5 | 1 of 5 | −8.8% |
| Jul | 5 | 1 of 5 | +0.34% |
| Aug | 6 | 5 of 6 | +11% |
| Sep | 6 | 2 of 6 | −4.8% |
| Oct | 6 | 2 of 6 | −10% |
| Nov | 5 | 0 of 5 | −8.0% |
| Dec | 5 | 4 of 5 | +29% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.